Cargando…
Human epidermal growth factor receptor-2 expression in locally advanced rectal cancer: Association with response to neoadjuvant therapy and prognosis
The aim of this study was to determine whether pretreatment status of human epidermal growth factor receptor-2 (HER-2) could predict pathologic response to neoadjuvant chemoradiotherapy (nCRT) and outcomes for patients with locally advanced rectal cancer (LARC). A total of 119 patients diagnosed wit...
Autores principales: | Meng, Xiangjiao, Wang, Renben, Huang, Zhaoqin, Zhang, Jianbo, Feng, Rui, Xu, Xiaoqing, Zhu, Kunli, Dou, Xue, Chen, Dong, Yu, Jinming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317932/ https://www.ncbi.nlm.nih.gov/pubmed/24730770 http://dx.doi.org/10.1111/cas.12421 |
Ejemplares similares
-
The prognostic role of EZH2 expression in rectal cancer patients treated with neoadjuvant chemoradiotherapy
por: Meng, Xiangjiao, et al.
Publicado: (2014) -
GOLPH3 overexpression correlates with poor response to neoadjuvant therapy and prognosis in locally advanced rectal cancer
por: Zhu, Kunli, et al.
Publicado: (2016) -
Prognostic value of serum γ-glutamyl transferase in unresectable hepatocellular carcinoma patients treated with transcatheter arterial chemoembolization combined with conformal radiotherapy
por: CHEN, DONG, et al.
Publicado: (2014) -
A comparison of liver protection among 3-D conformal radiotherapy, intensity-modulated radiotherapy and RapidArc for hepatocellular carcinoma
por: Chen, Dong, et al.
Publicado: (2014) -
Expression of Human Epidermal Growth Factor Receptor-2 in Resected Rectal Cancer
por: Meng, Xiangjiao, et al.
Publicado: (2015)